Panel Recommends Fda Approval Of Remicade Knockoff

An advisory panel to the FDA voted to recommend the agency approve the sale of a knockoff version of J&J’s arthritis drug Remicade, which had U.S. sales of $4.45 billion last year. The copy was developed by Celltrion and licensed to Pfizer.

Topics:  fda   j&j s   remicade   u.s    celltrion   pfizer   panel   knockoff   
BING NEWS:
  • Roche Highlights Inavolisib Market Prospects as Q1 Revenues Fall 6 Percent on Currency Headwinds
    The Swiss drugmaker expects a decision from the FDA on inavolisib as a treatment for PIK3CA-mutated breast cancer by the end of the year.
    04/24/2024 - 8:31 am | View Link
  • 'Restore Real Value': House Panel Wants to Give Junior Enlisted Troops 15% Pay Raise
    To fix that, the report recommends that E-1s through E-4s be given a 15% raise. For 2025, that would make the pay chart: $2,319.90 per month for E-1s $2,600.10 per month for E-2s $2,733.90 to $ ...
    04/11/2024 - 6:01 am | View Link
  • 10 doctors on FDA panel for Abbott heart device had financial ties to the company
    One member of the FDA advisory committee was linked to hundreds ... that those committees review as part of the regulatory approval process. The payments do not reflect wrongdoing on the part ...
    04/5/2024 - 11:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News